235 related articles for article (PubMed ID: 8500232)
1. The Vasodilator-Heart Failure Trials (V-HeFT). Mechanistic data from the VA Cooperative Studies. Introduction.
Cohn JN
Circulation; 1993 Jun; 87(6 Suppl):VI1-4. PubMed ID: 8500232
[No Abstract] [Full Text] [Related]
2. Effect of enalapril, hydralazine plus isosorbide dinitrate, and prazosin on hospitalization in patients with chronic congestive heart failure. The V-HeFT VA Cooperative Studies Group.
Loeb HS; Johnson G; Henrick A; Smith R; Wilson J; Cremo R; Cohn JN
Circulation; 1993 Jun; 87(6 Suppl):VI78-87. PubMed ID: 8500244
[TBL] [Abstract][Full Text] [Related]
3. Hydralazine and isosorbide dinitrate combination improves exercise tolerance in heart failure. Results from V-HeFT I and V-HeFT II. The V-HeFT VA Cooperative Studies Group.
Ziesche S; Cobb FR; Cohn JN; Johnson G; Tristani F
Circulation; 1993 Jun; 87(6 Suppl):VI56-64. PubMed ID: 8500241
[TBL] [Abstract][Full Text] [Related]
4. Plasma norepinephrine, plasma renin activity, and congestive heart failure. Relations to survival and the effects of therapy in V-HeFT II. The V-HeFT VA Cooperative Studies Group.
Francis GS; Cohn JN; Johnson G; Rector TS; Goldman S; Simon A
Circulation; 1993 Jun; 87(6 Suppl):VI40-8. PubMed ID: 8500238
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of serial changes in left ventricular ejection fraction in patients with congestive heart failure. The V-HeFT VA Cooperative Studies Group.
Cintron G; Johnson G; Francis G; Cobb F; Cohn JN
Circulation; 1993 Jun; 87(6 Suppl):VI17-23. PubMed ID: 8500235
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of death in heart failure. The Vasodilator-Heart Failure Trials. The V-HeFT VA Cooperative Studies Group.
Goldman S; Johnson G; Cohn JN; Cintron G; Smith R; Francis G
Circulation; 1993 Jun; 87(6 Suppl):VI24-31. PubMed ID: 8500236
[TBL] [Abstract][Full Text] [Related]
7. Influence of prerandomization (baseline) variables on mortality and on the reduction of mortality by enalapril. Veterans Affairs Cooperative Study on Vasodilator Therapy of Heart Failure (V-HeFT II). V-HeFT VA Cooperative Studies Group.
Johnson G; Carson P; Francis GS; Cohn JN
Circulation; 1993 Jun; 87(6 Suppl):VI32-9. PubMed ID: 8500237
[TBL] [Abstract][Full Text] [Related]
8. Lessons from V-HeFT: questions for V-HeFT II and the future therapy of heart failure.
Cohn JN
Herz; 1991 Sep; 16 Spec No 1():267-71. PubMed ID: 1820292
[TBL] [Abstract][Full Text] [Related]
9. The influence of atrial fibrillation on prognosis in mild to moderate heart failure. The V-HeFT Studies. The V-HeFT VA Cooperative Studies Group.
Carson PE; Johnson GR; Dunkman WB; Fletcher RD; Farrell L; Cohn JN
Circulation; 1993 Jun; 87(6 Suppl):VI102-10. PubMed ID: 8500233
[TBL] [Abstract][Full Text] [Related]
10. Ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio, ventricular arrhythmias, and plasma norepinephrine as determinants of prognosis in heart failure. The V-HeFT VA Cooperative Studies Group.
Cohn JN; Johnson GR; Shabetai R; Loeb H; Tristani F; Rector T; Smith R; Fletcher R
Circulation; 1993 Jun; 87(6 Suppl):VI5-16. PubMed ID: 8500240
[TBL] [Abstract][Full Text] [Related]
11. Enalapril decreases prevalence of ventricular tachycardia in patients with chronic congestive heart failure. The V-HeFT II VA Cooperative Studies Group.
Fletcher RD; Cintron GB; Johnson G; Orndorff J; Carson P; Cohn JN
Circulation; 1993 Jun; 87(6 Suppl):VI49-55. PubMed ID: 8500239
[TBL] [Abstract][Full Text] [Related]
12. Influence of age on mechanisms and prognosis of heart failure. The V-HeFT VA Cooperative Studies Group.
Hughes CV; Wong M; Johnson G; Cohn JN
Circulation; 1993 Jun; 87(6 Suppl):VI111-7. PubMed ID: 8500234
[TBL] [Abstract][Full Text] [Related]
13. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study.
Cohn JN; Archibald DG; Ziesche S; Franciosa JA; Harston WE; Tristani FE; Dunkman WB; Jacobs W; Francis GS; Flohr KH
N Engl J Med; 1986 Jun; 314(24):1547-52. PubMed ID: 3520315
[TBL] [Abstract][Full Text] [Related]
14. Incidence of thromboembolic events in congestive heart failure. The V-HeFT VA Cooperative Studies Group.
Dunkman WB; Johnson GR; Carson PE; Bhat G; Farrell L; Cohn JN
Circulation; 1993 Jun; 87(6 Suppl):VI94-101. PubMed ID: 8500246
[TBL] [Abstract][Full Text] [Related]
15. Evaluation by patients with heart failure of the effects of enalapril compared with hydralazine plus isosorbide dinitrate on quality of life. V-HeFT II. The V-HeFT VA Cooperative Studies Group.
Rector TS; Johnson G; Dunkman WB; Daniels G; Farrell L; Henrick A; Smith B; Cohn JN
Circulation; 1993 Jun; 87(6 Suppl):VI71-7. PubMed ID: 8500243
[TBL] [Abstract][Full Text] [Related]
16. Echocardiographic variables as prognostic indicators and therapeutic monitors in chronic congestive heart failure. Veterans Affairs cooperative studies V-HeFT I and II. V-HeFT VA Cooperative Studies Group.
Wong M; Johnson G; Shabetai R; Hughes V; Bhat G; Lopez B; Cohn JN
Circulation; 1993 Jun; 87(6 Suppl):VI65-70. PubMed ID: 8500242
[TBL] [Abstract][Full Text] [Related]
17. Vasodilators in heart failure. Conclusions from V-HeFT II and rationale for V-HeFT III.
Cohn JN
Drugs; 1994; 47 Suppl 4():47-57; discussion 57-8. PubMed ID: 7523062
[TBL] [Abstract][Full Text] [Related]
18. Mild systolic dysfunction in heart failure (left ventricular ejection fraction >35%): baseline characteristics, prognosis and response to therapy in the Vasodilator in Heart Failure Trials (V-HeFT).
Carson P; Johnson G; Fletcher R; Cohn J
J Am Coll Cardiol; 1996 Mar; 27(3):642-9. PubMed ID: 8606276
[TBL] [Abstract][Full Text] [Related]
19. Current indications for vasodilator therapy for left ventricular failure.
Franciosa JA
Compr Ther; 1985 Mar; 11(3):39-46. PubMed ID: 2983926
[No Abstract] [Full Text] [Related]
20. [Vasodilator agents in the therapeutic arsenal of cardiac insufficiency].
Lavitola Pde L; Higa SS
Rev Paul Med; 1986; 104(3):136-40. PubMed ID: 3563266
[No Abstract] [Full Text] [Related]
[Next] [New Search]
